Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KitazatoTSE:368A +0.79%22 Days Payable is 18.13 as of Mar. 2026, which is 15% below its 10-year median of 21.34. GuruFocus rates TSE:368A with a GF Score™ of 22/100. Among 794 Medical Devices & Instruments companies, Kitazato ranks worse than 93.07% on this metric.
Kitazato's average Accounts Payable for the
six
months ended in Mar. 2026 was 円194 Mil. Kitazato's Cost of Goods Sold for the
six
months ended in Mar. 2026 was 円1,948 Mil.
Hence, Kitazato's Days Payable for the
six
months ended in Mar. 2026 was 18.13.
The historical rank and industry rank for Kitazato's Days Payable or its related term are showing as below:
TSE:368A'
s Days Payable Range Over the Past 10 Years
Min: 18.19 Med: 21.34 Max: 23.13
Current: 20.83
During the past 4 years, Kitazato's highest Days Payable was 23.13. The lowest was 18.19. And the median was 21.34.
TSE:368A's Days Payable is ranked worse than 93.07% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs TSE:368A: 20.83
Kitazato's Days Payable
declined
from Mar. 2025 (19.40) to Mar. 2026 (18.13).
It may suggest that Kitazatoaccelerated paying its suppliers.
The historical data trend for Kitazato's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:368A vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Kitazato's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kitazato Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's Days Payable distribution charts can be found below:
* The bar in red indicates where Kitazato's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kitazato's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kitazato (TSE:368A) has a Days Payable of 18.13 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kitazato and its competitors. This is 15% below median its historical median of 21.34. Over the past decade, Kitazato's Days Payable has ranged from 18.19 to 23.13. According to the industry distribution chart, Kitazato ranks #739 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 93.1%.
Is Kitazato's Days Payable too high?
Kitazato's current Days Payable of 18.13 is 15% below median its 10-year median of 21.34. Over the past 10 years, this metric has ranged from a low of 18.19 to a high of 23.13. The Medical Devices & Instruments industry median Days Payable is 67.97. Kitazato's value of 18.13 is 73.3% below this industry median. Based on the distribution chart, Kitazato ranks #739 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Kitazato has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #739 out of 794 companies for Days Payable. This places Kitazato in the lower half of its industry. The industry median Days Payable is 67.97. Kitazato's value of 18.13 is 73.3% below this benchmark. Historically, Kitazato's own Days Payable has ranged from 18.19 to 23.13 over the past decade. While the company's 10-year median is 21.34 vs. the industry median of 67.97, Kitazato has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kitazato's current Days Payable of 18.13 is 73.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kitazato and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kitazato's current Days Payable is 18.13, which is 15% below median its own 10-year median of 21.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current Days Payable of 18.13. The current Days Payable is 18.13, which is 15% below median its 10-year median of 21.34 and 73.3% below the Medical Devices & Instruments industry median of 67.97. Kitazato's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kitazato (TSE:368A), the current Days Payable is 18.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
22GF Score
Get the complete analysis for TSE:368A
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:368A has been successfully added to your 
